Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00669383
Other study ID # OHSU eRIB#1845
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2001
Est. completion date November 2009

Study information

Verified date October 2018
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

One course of steroids given to a mother before a premature delivery helps the lungs of the premature infant and decreases breathing problems. One course of antenatal steroids is the standard of care for threatened premature deliveries. It is unclear as to how long the benefit of one course of steroids last. The most benefit to the baby's lungs seem to occur if the steroids are given at least 24 hours before but within 7 days of a premature delivery. It is difficult to predict the timing of a preterm delivery so deliveries often do not occur within this time period. We hypothesize that the benefits of the steroids to the lungs wear off if the steroids are given more than 14 days before a preterm delivery, and that in these circumstances an extra course of steroids will help the premature baby's lungs and the premature baby will have less breathing problems as shown by lung function testing.


Description:

The primary purpose of this randomized, blinded placebo controlled trial is to quantify and compare measurements of pulmonary function (including respiratory compliance and lung volumes/functional residual capacity) of hospitalized preterm infants whose mothers received an initial course of antenatal corticosteroids, remained undelivered after 14 days and at < 34 weeks of gestation, and were then randomized to either a rescue course of antenatal corticosteroids or to a rescue course of placebo. In addition, follow-up pulmonary function tests, clinical outcomes, growth parameters, and the neurodevelopmental outcome of these infants will be followed.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date November 2009
Est. primary completion date July 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years and older
Eligibility Inclusion Criteria:

- Greater than 14 days after first course of antenatal steroids;

- Less than 34 weeks of gestation;

- Identified by primary physician as continued risk for preterm delivery;

- Informed consent

Exclusion Criteria:

- Major congenital anomalies

- Multiple gestation of triplets or greater

- Mother with insulin dependent diabetes

Study Design


Intervention

Drug:
betamethasone
12 mg IM q 24 hours x 2 doses
placebo
Placebo IM q 24 hours x 2 doses

Locations

Country Name City State
United States Oregon Health & Science University Portland Oregon

Sponsors (2)

Lead Sponsor Collaborator
Oregon Health and Science University American Lung Association

Country where clinical trial is conducted

United States, 

References & Publications (4)

Jordan BK, Schilling D, McEvoy CT. Pulmonary Function at Hospital Discharge in Preterm Infants Randomized to a Single Rescue Course of Antenatal Steroids. J Pediatr. 2017 Feb;181:62-66.e1. doi: 10.1016/j.jpeds.2016.10.022. Epub 2016 Nov 7. — View Citation

Jordan BK, Schilling D, McEvoy CT. The window of improved neonatal respiratory compliance after rescue antenatal steroids. J Perinatol. 2018 Jul;38(7):828-833. doi: 10.1038/s41372-018-0124-9. Epub 2018 May 24. — View Citation

McEvoy C, Schilling D, Peters D, Tillotson C, Spitale P, Wallen L, Segel S, Bowling S, Gravett M, Durand M. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. Am J Obstet Gynecol. 2 — View Citation

McEvoy C, Schilling D, Spitale P, O'Malley J, Bowling S, Durand M. Pulmonary function and outcomes in infants randomized to a rescue course of antenatal steroids. Pediatr Pulmonol. 2017 Sep;52(9):1171-1178. doi: 10.1002/ppul.23711. Epub 2017 Apr 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Measurements of Functional Residual Capacity in Preterm Infants. Within first 72 hours after birth
Primary Measurements of Respiratory Compliance (Crs) in Preterm Infants. Within first 72 hours after birth
Secondary FiO2 During initial hospital stay and planned follow-up
See also
  Status Clinical Trial Phase
Completed NCT00779090 - Functional Residual Capacity (FRC) Guided Alveolar Recruitment Strategy Phase 4
Completed NCT05077605 - Effect of Extubation on Respiratory Function N/A
Completed NCT01962818 - High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance. N/A
Not yet recruiting NCT03511651 - The Effect of Positive End-Expiratory Pressure on Functional Residual Capacity During Mechanical Ventilation N/A